The North America Cancer Pain Management market is projected to grow from $3.26 Bn in 2022 to $4.57 Bn by 2030, registering a CAGR of 4.3% during the forecast period of 2022-2030. The main factors driving the growth would be the launch of advanced novel pain management drugs, increasing cancer incidence, and the growing need for non-invasive and minimally invasive pain management treatment. The market is segmented by drug type and by disease. Some of the major players include Collegium Pharmaceutical, Pfizer, Abbott, Sorrento Therapeutics, WEX Pharmaceuticals, and Tetra Bio-Pharma.
The North America Cancer Pain Management market is projected to grow from $3.26 Bn in 2022 to $4.57 Bn by 2030, registering a CAGR of 4.3% during the forecast period of 2022 - 2030. North America, which consists of the US and Canada, has one of the largest GDPs in the entire world. The GDP of North America is expected to reach $20.5 trillion in 2020, according to the World Bank. In North America, the cost of healthcare is often high even if it varies from country to country. The US spends 17.2% more on healthcare than any other country in North America as a proportion of GDP, according to the WHO. In Canada and Mexico, respectively, healthcare spending as a proportion of GDP was 10.3% and 6.2%.
Cancer-related treatments including chemotherapy and surgery as well as the disease itself may contribute to cancer discomfort. The form, location, and degree of pain experienced have an impact on the medications chosen and how they are used. Numerous different drugs are used to treat cancer pain. For instance, potent opioids are used to treat severe pain, whereas non-opioid medications like acetaminophen and NSAIDs are favored to treat mild to moderate cancer pain. The US is the largest market in North America for cancer pain management, accounting for a significant portion of the global market for cancer pain management.
Market Growth Drivers
The North America cancer pain management market is expected to be driven by factors such as the launch of advanced novel pain management drugs, increasing cancer incidence, and the growing need for non-invasive and minimally invasive pain management treatment. Moreover, the North American government has been funding programs like the National Cancer Institute's Pain Management Steering Committee that attempt to improve cancer patients' access to pain management therapies.
Market Restraints
Some pain relievers include side effects such as nausea, dizziness, urinary incontinence, sleep issues, and constipation, which can limit their use and have an impact on the growth of the cancer pain relief market. Furthermore, it is anticipated that rigorous laws and restrictions will limit market expansion. For instance, in order to deal with the opioid epidemic, Canadian regulators have imposed strict restrictions on the prescription of prescription opioids, which may limit the availability of these drugs for some cancer patients. In the US, FDA also maintains strict guidelines for new drug approval, which may cause delays in the development of new cancer pain management therapies.
Key Players
March 2022: Collegium Pharmaceutical acquired BioDelivery Sciences International (BDSI) to establish a premier, diverse specialty pharmaceutical company committed to improving the lives of patients with serious medical problems. It was planned for the acquisition to be a cash tender offer to buy all of the outstanding shares of BDSI for $5.60 each.
July 2020: The acquisition of Lumiera Health Innovation has been announced jointly by Tetra and Mondias. Tetra and Mondias jointly announced the acquisition of Lumiera Health Innovation. With this acquisition, Tetra is able to focus on what it does best: developing novel, medically effective cannabinoid-based medicines for ophthalmic diseases, chronic pain (both cancer-related and not-related to cancer), and advanced cancer pain.
The United States and Canada's laws and policies play a major role in determining the regulatory environment for the North American cancer pain treatment market. The U.S. Food and Drug Administration (FDA), which is in charge of approving medications for the treatment of cancer pain and supervising their usage and distribution, is the main regulatory organization in the country. The FDA also establishes requirements for the efficacy and safety of certain medications. Health Canada, which has a comparable function to the FDA in the approval, monitoring, and regulation of medications used for cancer pain treatment, has an impact on the regulatory environment in Canada. A number of specialized associations and organizations exist in both nations, including the American Pain Society and the Canadian Pain Society, which help to shape the regulatory environment by offering recommendations on the best ways to treat cancer pain. Additionally, the policies and regulations governing healthcare funding and payment, the accessibility of alternative treatments, and the cost-effectiveness of various medications all have an impact on the reimbursement picture for cancer pain management in North America.
Different countries and regions have different reimbursement policies for the North American cancer pain management market. The cost of cancer pain management treatments, such as prescription medications, medical equipment, and palliative care services, is covered by Medicare and Medicaid in the United States. These therapies are also covered by private insurance policies; however, the level of coverage varies by plan and policy. Canada's publicly financed healthcare system pays for the cost of cancer pain management therapies; however, the extent of coverage varies by province and by individual insurance plans. Furthermore, a lot of patients choose to pay out-of-pocket for complementary or alternative therapies like acupuncture or massage therapy.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Drug Type (Revenue, USD Billion):
Non-steroidal anti-inflammatory medicines relieve pain at the site of injury by blocking the cyclooxygenase enzyme, which prevents prostaglandin formation. NSAIDs are a class of medications that includes medications with analgesic, antipyretic, and, at higher doses, anti-inflammatory properties.
By Disease Indication (Revenue, USD Billion):
Based on disease Indication the market is segmented into:
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?